Identification of potent nanobodies to neutralize the most poisonous polypeptide from scorpion venom

Rahma Ben Abderrazek, Issam Hmila, Cécile Vincke, Zakaria Benlasfar, Mireille Pellis, Hafedh Dabbek, Dirk Saerens, Mohamed El Ayeb, Serge Muyldermans, Balkiss Bouhaouala-Zahar

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Scorpion venom, containing highly toxic, small polypeptides that diffuse rapidly within the patient, causes serious medical problems. Nanobodies, single-domain antigen-binding fragments derived from dromedary heavy-chain antibodies, have a size that closely matches that of scorpion toxins. Therefore these nanobodies might be developed into potent immunotherapeutics to treat scorpion envenoming. Multiple nanobodies of subnanomolar affinity to AahII, the most toxic polypeptide within the Androctonus australis hector venom, were isolated from a dromedary immunized with AahII. These nanobodies neutralize the lethal effect of AahII to various extents without clear correlation with the kinetic rate constants kon or koff, or the equilibrium dissociation constant, KD. One particular nanobody, referred to as NbAahII10, which targets a unique epitope on AahII, neutralizes 7 LD50 of this toxin in mice, corresponding to a neutralizing capacity of approx. 37000 LD50 of AahII/mg of nanobody. Such high neutralizing potency has never been reached before by any other monoclonal antibody fragment.

Original languageEnglish
Pages (from-to)263-272
Number of pages10
JournalBiochemical Journal
Volume424
Issue number2
DOIs
Publication statusPublished - 1 Dec 2009
Externally publishedYes

Fingerprint

Single-Domain Antibodies
Scorpion Venoms
Peptides
Scorpions
Camelus
Poisons
Lethal Dose 50
Immunoglobulin Fragments
Venoms
Medical problems
Epitopes
Rate constants
Monoclonal Antibodies
Antigens
Kinetics
Antibodies

Keywords

  • Anti-venom
  • Dromedary
  • Recombinant antibody
  • Scorpion toxin
  • Single-domain antibody

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Abderrazek, R. B., Hmila, I., Vincke, C., Benlasfar, Z., Pellis, M., Dabbek, H., ... Bouhaouala-Zahar, B. (2009). Identification of potent nanobodies to neutralize the most poisonous polypeptide from scorpion venom. Biochemical Journal, 424(2), 263-272. https://doi.org/10.1042/BJ20090697

Identification of potent nanobodies to neutralize the most poisonous polypeptide from scorpion venom. / Abderrazek, Rahma Ben; Hmila, Issam; Vincke, Cécile; Benlasfar, Zakaria; Pellis, Mireille; Dabbek, Hafedh; Saerens, Dirk; El Ayeb, Mohamed; Muyldermans, Serge; Bouhaouala-Zahar, Balkiss.

In: Biochemical Journal, Vol. 424, No. 2, 01.12.2009, p. 263-272.

Research output: Contribution to journalArticle

Abderrazek, RB, Hmila, I, Vincke, C, Benlasfar, Z, Pellis, M, Dabbek, H, Saerens, D, El Ayeb, M, Muyldermans, S & Bouhaouala-Zahar, B 2009, 'Identification of potent nanobodies to neutralize the most poisonous polypeptide from scorpion venom', Biochemical Journal, vol. 424, no. 2, pp. 263-272. https://doi.org/10.1042/BJ20090697
Abderrazek, Rahma Ben ; Hmila, Issam ; Vincke, Cécile ; Benlasfar, Zakaria ; Pellis, Mireille ; Dabbek, Hafedh ; Saerens, Dirk ; El Ayeb, Mohamed ; Muyldermans, Serge ; Bouhaouala-Zahar, Balkiss. / Identification of potent nanobodies to neutralize the most poisonous polypeptide from scorpion venom. In: Biochemical Journal. 2009 ; Vol. 424, No. 2. pp. 263-272.
@article{7b19e776bd7c424aa421dddeb2e53775,
title = "Identification of potent nanobodies to neutralize the most poisonous polypeptide from scorpion venom",
abstract = "Scorpion venom, containing highly toxic, small polypeptides that diffuse rapidly within the patient, causes serious medical problems. Nanobodies, single-domain antigen-binding fragments derived from dromedary heavy-chain antibodies, have a size that closely matches that of scorpion toxins. Therefore these nanobodies might be developed into potent immunotherapeutics to treat scorpion envenoming. Multiple nanobodies of subnanomolar affinity to AahII, the most toxic polypeptide within the Androctonus australis hector venom, were isolated from a dromedary immunized with AahII. These nanobodies neutralize the lethal effect of AahII to various extents without clear correlation with the kinetic rate constants kon or koff, or the equilibrium dissociation constant, KD. One particular nanobody, referred to as NbAahII10, which targets a unique epitope on AahII, neutralizes 7 LD50 of this toxin in mice, corresponding to a neutralizing capacity of approx. 37000 LD50 of AahII/mg of nanobody. Such high neutralizing potency has never been reached before by any other monoclonal antibody fragment.",
keywords = "Anti-venom, Dromedary, Recombinant antibody, Scorpion toxin, Single-domain antibody",
author = "Abderrazek, {Rahma Ben} and Issam Hmila and C{\'e}cile Vincke and Zakaria Benlasfar and Mireille Pellis and Hafedh Dabbek and Dirk Saerens and {El Ayeb}, Mohamed and Serge Muyldermans and Balkiss Bouhaouala-Zahar",
year = "2009",
month = "12",
day = "1",
doi = "10.1042/BJ20090697",
language = "English",
volume = "424",
pages = "263--272",
journal = "Biochemical Journal",
issn = "0264-6021",
publisher = "Portland Press Ltd.",
number = "2",

}

TY - JOUR

T1 - Identification of potent nanobodies to neutralize the most poisonous polypeptide from scorpion venom

AU - Abderrazek, Rahma Ben

AU - Hmila, Issam

AU - Vincke, Cécile

AU - Benlasfar, Zakaria

AU - Pellis, Mireille

AU - Dabbek, Hafedh

AU - Saerens, Dirk

AU - El Ayeb, Mohamed

AU - Muyldermans, Serge

AU - Bouhaouala-Zahar, Balkiss

PY - 2009/12/1

Y1 - 2009/12/1

N2 - Scorpion venom, containing highly toxic, small polypeptides that diffuse rapidly within the patient, causes serious medical problems. Nanobodies, single-domain antigen-binding fragments derived from dromedary heavy-chain antibodies, have a size that closely matches that of scorpion toxins. Therefore these nanobodies might be developed into potent immunotherapeutics to treat scorpion envenoming. Multiple nanobodies of subnanomolar affinity to AahII, the most toxic polypeptide within the Androctonus australis hector venom, were isolated from a dromedary immunized with AahII. These nanobodies neutralize the lethal effect of AahII to various extents without clear correlation with the kinetic rate constants kon or koff, or the equilibrium dissociation constant, KD. One particular nanobody, referred to as NbAahII10, which targets a unique epitope on AahII, neutralizes 7 LD50 of this toxin in mice, corresponding to a neutralizing capacity of approx. 37000 LD50 of AahII/mg of nanobody. Such high neutralizing potency has never been reached before by any other monoclonal antibody fragment.

AB - Scorpion venom, containing highly toxic, small polypeptides that diffuse rapidly within the patient, causes serious medical problems. Nanobodies, single-domain antigen-binding fragments derived from dromedary heavy-chain antibodies, have a size that closely matches that of scorpion toxins. Therefore these nanobodies might be developed into potent immunotherapeutics to treat scorpion envenoming. Multiple nanobodies of subnanomolar affinity to AahII, the most toxic polypeptide within the Androctonus australis hector venom, were isolated from a dromedary immunized with AahII. These nanobodies neutralize the lethal effect of AahII to various extents without clear correlation with the kinetic rate constants kon or koff, or the equilibrium dissociation constant, KD. One particular nanobody, referred to as NbAahII10, which targets a unique epitope on AahII, neutralizes 7 LD50 of this toxin in mice, corresponding to a neutralizing capacity of approx. 37000 LD50 of AahII/mg of nanobody. Such high neutralizing potency has never been reached before by any other monoclonal antibody fragment.

KW - Anti-venom

KW - Dromedary

KW - Recombinant antibody

KW - Scorpion toxin

KW - Single-domain antibody

UR - http://www.scopus.com/inward/record.url?scp=70450178687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70450178687&partnerID=8YFLogxK

U2 - 10.1042/BJ20090697

DO - 10.1042/BJ20090697

M3 - Article

VL - 424

SP - 263

EP - 272

JO - Biochemical Journal

JF - Biochemical Journal

SN - 0264-6021

IS - 2

ER -